| Literature DB >> 33925742 |
Gabriele Cervino1, Agron Meto2, Luca Fiorillo1,3, Alessandra Odorici4, Aida Meto5, Cesare D'Amico1, Giacomo Oteri1, Marco Cicciù1.
Abstract
Recently, interest has grown by focusing on the evaluation of a molecule already produced in the human body such as hyaluronic acid (HA), as an application to the surface of the titanium implant. Its osteo-conductive characteristics and positive interaction with the progenitor cells responsible for bone formation, consequently, make it responsible for secondary stability. The aim of this work was to analyze the various surface treatments in titanium implants, demonstrating that the topography and surface chemistry of biomaterials can correlate with the host response; also focusing on the addition of HA to the implant surface and assessing the biological implications during early stages of recovery. Used as a coating, HA acts on the migration, adhesion, proliferation and differentiation of cell precursors on titanium implants by improving the connection between implant and bone. Furthermore, the improvement of the bioactivity of the implant surfaces through HA could therefore facilitate the positioning of the dental prosthesis precisely in the early loading phase, thus satisfying the patients' requests. It is important to note that all the findings should be supported by further experimental studies in animals as well as humans to evaluate and confirm the use of HA in any field of dentistry.Entities:
Keywords: dental implant; hyaluronic acid; surface treatment
Year: 2021 PMID: 33925742 PMCID: PMC8125310 DOI: 10.3390/ijerph18094670
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Classification of titanium.
| Alloy | Chemical Composition |
|---|---|
| Grade I | Ti (2.15 Fe; 0.12 O2) |
| Grade II | Ti (0.20 Fe; 0.18 O2) |
| Grade III | Ti (0.25 Fe; 0.25 O2) |
| Grade IV | Ti (0.30 Fe; 0.35 O2) |
| Grade V | Ti (0.06 Al; 0.04 V) |
Dental implant titanium alloys XRF (X-Ray Fluorescence) results.
|
| Titanium (Ti) (91.9%) |
Figure 1SLA surface confocal microscopy.
TNF-α expression on both groups evaluated by the immunohistochemical tests.
| Control Group | Test Group | |
|---|---|---|
| 1 week | Antibody positivity for fibroblasts, osteoblasts and endothelial cells. Negativity for osteoid cells | Antibody positivity for fibroblast, osteoblast, osteocites, adipocites and endothelial cells. |
| 2 weeks | Bone marrow stem cells, osteoblasts, osteoclasts and osteocites antibody positivity. | Bone marrow stem cells, osteoblasts, osteoclasts and osteocites antibody positivity. |
| 4 weeks | Bone marrow stem cells, osteoblasts, osteoclasts and osteocites antibody positivity. | Bone marrow stem cells, osteoblasts, osteoclasts and osteocites antibody positivity. |
Histomorphometric analysis.
| Area | Control Group | Test Group |
|---|---|---|
| Bone | 2697.7 | 3252.3 |
| Bone with osteoid tissue | 4704.1 | 5887.3 |
BIC, BAIT and BAOT evaluation of both groups.
| Control Group | Test Group | |
|---|---|---|
| 15 days | Trabecular bone near to dental implant surface. Few inflammatory cells. Mean BIC 22.42 ± 4.5%, | Trabecular bone near to dental implant surface. Numerous osteoblast in contact with dental implant surface. |
| 30 days | Mature bone in contact with dental implant surface. Osteoblasts presence and absence of inflammatory exudate. Mean BIC 51.2 ± 3.9%, BAIT 28 ± 0.8%, | Mature bone with Haversian organization in contact with dental implant surface. Osteoblasts activity. Mean BIC 55.3 ± 3.2%, BAIT 39 ± 2.2%, BAOT 38 ± 2.2% |
| 60 days | Mature bone in contact with dental implant surface. Osteoblasts activity. Mean BIC 53.32 ± 3.2%, | Mature bone organization in contact with dental implant surface. |